1Ito H, Maruyama A, Iwakura K, Takiuchi S, Masuyama T, Hori M, et al. (1996) Clinical implications of the ‘no-reflow’ phenomenon: A predictor of complications and left ventricular remodeling in perfused anterior wall myocardial infarction. Circulation 93: 223–228.

2Tsukahara K, Kimura K, Kosuge M, Shimizu T, Sugano T, Hibi K, et al. (2005) Clinical implications of intermediate QRS prolongation in the absence of bundle-branch block in patients with ST-segment-elevation acute myocardial infarction. Circ J 69: 29 – 34.

3Fehmi Kacmaz, Orhan Maden, Cagın Ureyen, et al. (2008) Relationship of Admission QRS Duration and Changes in QRS Duration with Myocardial Reperfusion in Patients with Acute ST-Segment Elevation Myocardial Infarction (STEMI) Treated with Fibrinolytic Therapy. Circ J 72: 873–879.

4Radek Pudil, Micha S Feinberg, Hanoch Hod, Valentina Boyko, et al. (2001) The prognostic significance of intermediate QRS prolongation in acute myocardial infarction. International Journal of Cardiology 78:233–239.

5Elhendy A, Hammill S.C, Mahoney D.W, Pellikka P.A (2005) Relation of QRS duration on the surface 12-lead electrocardiogram with mortality in patients with known or suspected coronary artery disease. Am J Cardiol 96:1082-1088.

6Pudil R, Feinberg M.S, Hod H, Boyko V, Mandelzweig L, Behar S (2001) The prognostic significance of intermediate QRS prolongation in acute myocardial infarction. Int J Cardiol 78:233-239.

7Hathaway W.R, Peterson E.D, Wagner G.S, et al. (1998) Prognostic significance of the initial electrocardiogram in patients with acute myocardial infarction. GUSTO-I Investigators. Global Utilization of Streptokinase and t-PA for Occluded Coronary Arteries. JAMA 279:387-391.

8Brilakis E.S, Mavrogiorgos N.C, Kopecky S.L, et al. (2002) Usefulness of QRS duration in the absence of bundle branch block as an early predictor of survival in non-ST elevation acute myocardial infarction. Am J Cardiol 89:1013-1018.

9C-K Wong, W Gao, R A H Stewart, J K French, P E G Aylward (2009) H D White. Relationship of QRS duration at baseline and changes over 60 min after fibrinolysis to 30-day mortality with different locations of ST-elevation myocardial infarction: results from the Hirulog and Early Reperfusion or Occlusion-2 trial. Heart 95: 276-282.

10A A Cantor, B Goldfarb, R Ilia (2000) QRS prolongation: a sensitive marker of ischemia during percutaneous transluminal coronary angioplasty. Catheterization and Cardiovascular Interventions (Impact Factor: 2.51). 50:177-83.

11Lakshmi Narayan Yerra, Nagesh Anavekar, MD, Hicham Skali, MD, Steve Zelenkofske, DO Eric Velazquez, MD, et al. (2006) Association of QRS duration and outcomes after myocardial infarction: the VALIANT trial. Heart Rhythm Volume 3: 313–316.

12Schinkel AF, Elhendy A, van Domburg RT, Biagini E, Rizzello V, Veltman CE, et al. (2009) Prognostic significance of QRS duration in patients with suspected coronary artery disease referred for noninvasive evaluation of myocardial ischemia. Am J Cardiol. 104:1490-1493.

13M Orhan, Kacmaz F, Alyan O, Atak R, Senen K, Balbay Y, et al. (2007) A new electrocardiographic marker of successful myocardial reperfusion in patients undergoing primary angioplasty: resolution of QRS prolongation. Journal of Electro cardiology 40:51.

14Cantor AA, Goldfarb B, Ilia R (2000) QRS prolongation: A sensitive marker of ischemia during percutaneous transluminal coronary angioplasty. Cathet Cardiovasc Intervent 50: 177-183.

15Pfeffer MA, McMurray JJ, Velazquez EJ, Rouleau JL, Kober L, et al. (2003) For the Valsartan in Acute Myocardial Infarction Trial Investigators. Valsartan, captopril, or both in myocardial infarction complicated by heart failure, left ventricular dysfunction, or both. N Engl J Med 349:1893-906.

16Lakshmi Narayan Y, Anavekar NS, Velazquez E, McMurray JJ, Skali H, Califf R, et al. (2004) Association of QRS duration and outcomes after myocardial infarction: The VALIANT trial. Circulation 110: III-725.

17Schinkel FL, E Abdou, Domburg RT, Biagini E, Rizzello V, Veltman CE, et al. (2009) Prognostic Significance of QRS Duration in Patients With Suspected Coronary Artery Disease Referred for Noninvasive Evaluation of Myocardial Ischemia Arend. Am J Cardiol 104:1490 – 1493.